氯雷他定联合顺尔宁治疗小儿咳嗽变异性哮喘15例临床效果观察

Clinical Efficacy of Clarityne Combined Singulair in Treatment of Children with Cough Variant Asthma:an Observation of 15 Cases

目的 探讨开瑞坦联合顺尔宁治疗小儿咳嗽变异性哮喘的临床疗效。方法 选择我院收治的2014年5月-2015年1月30例小儿咳嗽变异性哮喘患者为研究对象,随机分组,对照组患者采用常规性治疗方案,观察组患者采用开瑞坦联合顺尔宁进行治疗。比较两组的临床疗效。结果 观察组患者总有效率与对照组患者相比优势明显（P〈0.05）。结论 开瑞坦与顺尔宁联合治疗小儿咳嗽变异性哮喘患者的效果明显,无明显不良反应,安全性高。

Objective To discuss clinical efficacy of Clarityne combined Singulair in treatment of children with cough variant asthma. Methods Selected 30 patients from May 2014 to January 2015 were randomly divided into control group and control group. Control group was treated with conventional treatment, and the observation group was treated with Clarityne combined Singulair. Results Compared with the control group,the total effective rate of the observation group was significantly higher than that of the control group（P〈0.05）. Conclusion Clarityne combined Singulair in treatment of children with cough variant asthma patients shows obvious effect,without obvious adverse reactions.